Yohei Sotomi

Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial

Patrick W. Serruys, Bernard Chevalier, Yohei Sotomi et al. · The Lancet · 2016 · 534 citations · Full text

Percutaneous Coronary Intervention, Absorb Ii, Everolimus-eluting Metallic Stent +10

Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction—TROFI II trial

Manel Sabaté, Stephan Windecker, Andrés Íñiguez et al. · European Heart Journal · 2015 · 219 citations · Full text

Sex Differences in Heart Failure With Preserved Ejection Fraction

Yohei Sotomi, Shungo Hikoso, Daisaku Nakatani et al. · Journal of the American Heart Association · 2021 · 194 citations · Full text

Two-year clinical, angiographic, and serial optical coherence tomographic follow-up after implantation of an everolimus-eluting bioresorbable scaffold and an everolimus-eluting metallic stent: insights from the randomised ABSORB Japan trial

Yoshinobu Onuma, Yohei Sotomi, Hiroki Shiomi et al. · EuroIntervention · 2016 · 139 citations

Outcomes After Percutaneous Coronary Intervention or Bypass Surgery in Patients With Unprotected Left Main Disease

Rafael Cavalcante, Yohei Sotomi, Cheol W. Lee et al. · Journal of the American College of Cardiology · 2016 · 125 citations

Percutaneous Coronary Intervention, Cardiac Surgery, Cardiovascular Disease +9